Clinical Trial Update: Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial investigating baclofen to prevent postoperative nausea and vomiting after bariatric surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Postoperative Nausea and Vomiting

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

Sponsor: Tanta University | Conditions: Postoperative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy | Phase 2, Phase 3 | Status: COMPLETED